| Literature DB >> 31607791 |
Saeed Alborzi1, Ziba Zahiri Sorouri2, Elham Askari1, Tahereh Poordast3, Kefayat Chamanara1.
Abstract
BACKGROUND: Endometriosis is seen in 0.5%-5% of fertile and 25%-40% of infertile women. To investigate this conflict between gynecologists that ovarian endometriomas should be removed or not before making any decision about pregnancy among infertile women, the authors decided to carry out a systematic review and meta-analysis to compare the effect of various available therapeutic methods and notice the impact of these options on women's pregnancy rate.Entities:
Keywords: endometriosis; female; infertility; pregnancy rate; reproduction
Year: 2019 PMID: 31607791 PMCID: PMC6780037 DOI: 10.1002/rmb2.12286
Source DB: PubMed Journal: Reprod Med Biol ISSN: 1445-5781
Quality of studies using NIH's quality assessment for cohort and cross‐sectional studies
| Criteria | Bila et al | Alborzi et al | Busacca et al | Alborzi et al | Pabuccu et al | Demirol et al | Fisch et al | Suganuma et al |
|---|---|---|---|---|---|---|---|---|
| 1. Was the research question or objective in this article clearly stated? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 2. Was the study population clearly specified and defined? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 3. Was the participation rate of eligible persons at least 50%? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 4. Were all the patients selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for being in the study prespecified and applied uniformly to all participants? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | NR |
| 5. Was a sample size justification, power description, or variance and effect estimates provided? | NR | ✓ | NR | NR | NR | ✓ | ✓ | ✓ |
| 6. For the analyses in this article, were the exposure(s) of interest measured prior to the outcome(s) being measured? | ✓ | NR | NR | NR | NR | NR | NR | NR |
| 7. Was the time frame sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed? | ✓ |
| ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 8. For exposures that can vary in amount or level, did the study examine different levels of the exposure as related to the outcome (eg, categories of exposure, or exposure measured as continuous variable)? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 9. Were the exposure measures (independent variables) clearly defined, valid, reliable, and implemented consistently | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 10. Was the exposure(s) assessed more than once over time? | ✓ | NR | NR | NR | NR | NR | NR | NR |
| 11. Were the outcome measures (dependent variables) clearly defined, valid, reliable, and implemented consistently across all study participants? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 12. Were the outcome assessors blinded to the exposure status of participants? | NR | NR | NR | NR | NR | NR | NR | NR |
| 13. Was loss to follow‐up after baseline 20% or less? | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ |
| 14. Were key potential confounding variables measured and adjusted statistically for their impact on the relationship between exposure(s) and outcome(s)? | ✓ | ✓ | ✓ | ✓ | ✓ | × | × | × |
Abbreviation: NR, not reported.
Figure 1Flowchart describing the study design process
Main characteristics of the included studies on treatment methods of endometriosis and its effect on clinical pregnancy rate as an outcome
| Article's | Population | Endometriosis groups | Diagnosis | Design | Outcomes | References |
|---|---|---|---|---|---|---|
|
Bila et al 2018, Serbia | 73 patients with primary infertility caused by endometriosis were subjected to 77 IVF/ICSI cycles at tertiary institutions for a period of 5 y in Medical faculty University of Belgrade, Serbia. | Patients were classified into two groups. (Group I, n = 46) Some kind of endometriosis treatment had previously been applied before the introduction to the IVF/ICSI, with two subgroups: (A) combination of surgical and medical treatment (n = 25) and (B) only surgically treated (n = 21) and (Group II, n = 27) patients were immediately subjected to the IVF/ICSI procedures. | Ultrasound and diagnostic laparoscopy without intervention | Prospective cohort study | Pregnancy rate |
|
|
Alborzi et al, 2007, Iran | To compare the ovary that had been operated on (cystectomy or fenestration coagulation) with the unoperated contralateral one of the same patients with respect to COH. From January 2002 to September 2005, 81 patients with infertility due to endometriosis were subjected for study. | Patients were divided into three groups: Group 1 (n = 24) and Group 2 (n = 41) with unilateral OMAs underwent fenestration and coagulation or the cystectomy. Group 3 (n = 16) patients with bilateral OMAs that ovarian cystectomy was done in one side and fenestration and coagulation in other side. (We omitted this group from our review). All patients referred for COH after surgery. | Ultrasound | Prospective randomized design study |
Ovarian response to COH after surgery |
|
|
Busacca et al, 2006, Italy | Patients who had been operated on for bilateral ovarian endometriosis between January 1995 and December 2003 were included. | Sixty‐five women of these population tried to become pregnant after surgery, 43 of them had at least 1 pregnancy (66.2%). Between 18 infertile women at the time of surgery, 9 of them subsequently conceived (50%). | Ultrasound and histopathology confirmation | Prospective study |
Postsurgical ovarian failure |
|
|
Alborzi et al, 2004, Iran | To determine the difference between two laparoscopic methods for the management of endometriomas with regard to the recurrence of signs and symptoms and pregnancy rate in 100 patients with unilateral OMAs from March 1998 to December 2001. Patients followed up at 3, 6, 9, 12, 18, and 24 months after surgery. | Patients divided into two groups: Group 1 (n = 52) in the cystectomy group and Group 2 (n = 48) in fenestration and coagulation group. There were 19 pregnancies among 32 infertile patients in Group 1 (59.4%) and 7 pregnancies among 30 infertile patients in Group 2 (23.3%) after 1‐y follow‐up without any medications. | Ultrasound and histopathology confirmation | Prospective, randomized clinical trial | Recurrence of signs and symptoms and pregnancy rate according to two laparoscopic methods. |
|
|
Pubuccu et al, 2004, Turkey | Between January 1999 and August 2002, 171 patients went through 171 ICSI cycles with ejaculated sperm at the Assisted Reproduction Unit of the Gulhane School of Medicine Department of Obstetrics and Gynecology | Patients were divided into four groups: aspiration of OMAs at the beginning of controlled ovarian hyperstimulation (COH) in patients with ovarian OMAs and no history of previous surgery (n _ 41) (Group 1); nonaspirated OMAs (n _ 40) (group 2); history of ovarian surgery for OMAs in patients without ovarian OMAs at the beginning of COH (n _ 44) (Group 3); and tubal factor infertility (n _ 46) (control Group 4). In Group 3, we have 23 bilateral and 21 patients with unilateral OMA, and endometriosis was resected twice in 11 women and once in 33 women. | Ultrasound and histopathology confirmation | Prospective study. |
Intracytoplasmic sperm injection (ICSI) outcomes |
|
| Demirole et al, 2006, Turkey N = 99 | Ninety‐nine patients with unilateral OMAs with the diameter between 3 and 6 cm were referred to an intracytoplasmic sperm injection (ICSI) cycle at the Clinic Women Health, Infertility and IVF Centre, Ankara, Turkey, between January 2001 and March 2005 | Patients were divided into two groups: Patients in Group I (49 patients) underwent conservative ovarian surgery before the ICSI cycle and patients in Group II (50 patients) underwent the ICSI cycle directly. The rate of male factor infertility was similar in both groups (59.18 vs 62.00). All patients were stimulated with luteal long protocol. | Ultrasound | Prospective, randomized study | Intracytoplasmic sperm injection (ICSI) outcomes ‐Pregnancy rate |
|
|
Fisch et al, 2004, US | Infertile women (n = 32) with OMAs were offered sclerotherapy in lieu of surgery. Patients’ cysts ranged in size between 1.5 and 6.0 cm. Patients were eligible for IV treatment if OMAs were resolved 6 wk after sclerotherapy. | In 24 (75%) of 32 patients, the OMAs were completely resolved at the 6‐wk follow‐up. Eight patients had a residual simple cyst that required repeat aspiration before complete resolution. Two patients needed an additional treatment with TCN. We have 57% (n = 16) ongoing pregnancy rate after sclerotherapy between 28 infertile women. | Ultrasound | Prospective, cohort. |
Resolution of OMA |
|
| Suganum et al, 2002, Japan N = 79 | 79 infertile women with OMAs who underwent IVF‐ET were selected to evaluate the effect of pretreatments for OMAs before IVF cycle in Japan. | 79 infertile women with OMAs who underwent IVF‐ET were divided into 3 groups as follows: (1) 62 IVF cycles in 36 patients who underwent laparotomy or laparoscopy (“Surgery” group), (2) 35 cycles in 23 patients for whom the OMA content was aspirated and treated with or without alcohol fixation (“Cyst aspiration” group), and (3) 30 cycles in 20 patients who did not undergo pretreatment and confirmed ovarian endometriosis at oocyte retrieval (“No treatment” group). Ovarian hyperstimulation was performed following a short, long, and ultralong protocols. | Ultrasound | Prospective study |
IVF‐ET outcome |
|
Description of patients in relation to pregnancy outcome and endometriosis therapy
| Methods of intervention | Number of infertile women | Number of pregnancy | Pregnancy rate % | Duration of follow‐up |
|---|---|---|---|---|
| Surgery + ART | 243 | 93 | 38.7 | 1‐2 cycles |
| Surgery | 80 | 35 | 43.7 | 2 y |
| Aspiration ± sclerotherapy + ART | 142 | 56 | 39.4 | 1‐2 cycles |
| ART | 88 | 26 | 29.5 | 1‐2 cycles |
| Total | 553 | 210 | 37.9 | ‐ |
Med Calc of the systematic review and meta‐analysis based on methods and pregnancy outcome
| Sample size | Proportion (%) Pregnancy | 95% CI | Weight (%) |
| Sig. diff | ||
|---|---|---|---|---|---|---|---|
| Fixed | Random | ||||||
| Study (Group 1 = surgery + ART) | |||||||
| Pabuccu et al | 44 | 27.273 | 14.958‐42.790 | 18.07 | 17.74 | ||
| Demirol et al | 49 | 34.694 | 21.672‐49.639 | 20.08 | 18.93 | ||
| Suganuma et al | 36 | 50.000 | 32.922‐67.078 | 14.86 | 15.62 | ||
| Bila et al | 49 | 48.980 | 34.425‐63.662 | 20.08 | 18.93 | ||
| Alborzi et al | 41 | 36.585 | 22.123‐53.064 | 16.87 | 16.98 | ||
| Alborzi et al | 24 | 29.167 | 12.615‐51.095 | 10.04 | 11.81 | ||
| Total (fixed effects) | 243 | 38.380 | 32.310‐44.731 | 100.00 | 100.00 | 35.16 | 0.1729 |
| Study (Group 2 = surgery) | |||||||
| Alborzi et al | 32 | 59.375 | 40.645‐76.302 | 39.76 | 34.93 | ||
| Alborzi et al | 30 | 23.333 | 9.934‐42.284 | 37.35 | 34.50 | ||
| Busacca et al | 18 | 50.000 | 26.019‐73.981 | 22.89 | 30.58 | ||
| Total (random effects) | 80 | 43.848 | 22.504‐66.466 | 100.00 | 100.00 | 77.36 | 0.0121 |
| Study (Group 3 = aspiration±sclerotherapy + ART) | |||||||
| Pabuccu et al | 41 | 24.390 | 12.363‐40.305 | 28.77 | 26.73 | ||
| Fisch et al | 28 | 57.143 | 37.179‐75.538 | 19.86 | 23.38 | ||
| Suganuma et al | 23 | 47.826 | 26.820‐69.412 | 16.44 | 21.55 | ||
| Demirole et al | 50 | 38.000 | 24.650‐52.825 | 34.93 | 28.34 | ||
| Total (random effects) | 142 | 40.853 | 27.791‐54.609 | 100.00 | 100.00 | 64.18 | 0.0389 |
| Study (Group 4 = ART) | |||||||
| Bila et al | 28 | 25.000 | 10.691‐44.872 | 31.87 | 33.42 | ||
| Pabuccu et al | 40 | 20.000 | 9.052‐35.648 | 45.05 | 36.26 | ||
| Suganuma et al | 20 | 55.000 | 31.528‐76.942 | 23.08 | 30.33 | ||
| Total (random effects) | 88 | 32.088 | 15.078‐52.024 | 100.00 | 100.00 | 73.40 | 0.0233 |
Description of the cycle (IVF/ICSI) in relation to outcome
| Author name | Treatment methods | Basal FSH | Basal E2 | Dose of gonadotropins (IU) | Duration of stimulation | Estradiol at the day of HCG | Total oocyte number | MII oocyte number | Implantation rate | Fertilization rate (%) | Clinical pregnancy rate |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Bila et al | Surgery + ART | 7.43 ± 3.78 | 41.75 ± 21.13 | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | ‐ | 24 (77.4) |
| ART | 6.81 ± 3.24 | 49.42 ± 41.39 | ‐ | ‐ | 7 (22.6) | ||||||
| Pabuccu et al | Aspiration + ART | 7.2 ± 1.7 | 62.4 ± 17.5 | 2512.5 ± 547.5 | 10.9 ± 1.4 | 1632 ± 670 | ‐ | 6.1 ± 1.1 | 13 | 72 ± 10 | 10 (24) |
| ART | 6.8 ± 1.8 | 66.7 ± 18. 4 | 2760 ± 742.5 | 11.6 ± 1.6 | 946.7 ± 264 | ‐ | 5.6 ± 1.2 | 12 | 68 ± 16 | 8 (20) | |
| Surgery + ART | 7.1 ± 1.7 | 62.4 ± 16.6 | 2490 ± 622.5 | 10.5 ± 1.6 | 1196 ± 444 | ‐ | 5.7 ± 1.13 | 18 | 72 ± 13 | 12 (25) | |
| Demirol et al | Surgery + ART | 8.2 ± 0.36 | ‐ | 4575 ± 530 | 14 ± 2.5 | 1170 ± 417 | 7.8 ± 3 | ‐ | 16.5 | 86.2 | 17 (34.4) |
| Aspiration + ART | 7.9 ± 0.36 | ‐ | 3675 ± 792.58 | 10.8 ± 2.6 | 1680 ± 428.69 | 8.6 ± 2.82 | ‐ | 18.5 | 88.3 | 19 (38.2) | |
| Suganuma et al | ART | ‐ | ‐ | ‐ | ‐ | ‐ | 9.7 ± 6.7 | 8 ± 5. 4 | ‐ | 56.5 | 11 (55) |
| Surgery + ART | ‐ | ‐ | ‐ | ‐ | ‐ | 7.2 ± 6.2 | 5.7 ± 4.8 | ‐ | 56.8 | 18 (50) | |
| Sclerotherapy + ART | ‐ | ‐ | ‐ | ‐ | ‐ | 6.6 ± 5.5 | 5.1 ± 3.7 | ‐ | 67.4 | 11 (47.8) |